21.06.2024 00:55 - About Us - Mediadaten - Imprint & Contact - succidia AG
Scientist > Prof Dr Reinhard Renneberg

Prof Dr Reinhard Renneberg

// born 1951, studied chemistry at Lomonossov University, Moscow

// After obtaining a diploma he moved to the Zentral­institut für Molekularbiologie (ZIM) [Central Mole­cular Biology Institute] in Berlin-Buch, where he acquired a doctorate in 1978 and became a Professor of Biosensorics in 1991

// From 1991 to 1995 he directed the Immunosensorics Division of the Fraunhofer Institute for Chemical and ­Biosensorics (ICB) in Münster

// In 1994 he followed the call of the Hong Kong University of ­Science and Technology (HKUST), becoming a Full Professor of Analytical Biotechnology

// ­Professor Renneberg has also been active in setting up companies and as the Scientific ­Director of R&C Biogenius Ltd. He is the author of ‘Bioanalytics for Beginners’ and ‘Biotechnology ­for Beginners’, for which he won the Literary Prize of the Fonds der Chemischen Industrie [Chemical­ Industry Fund] in 2008

Contact: laborundmore@succidia.de

Nano Crystals for mega Fluorescence Amplification

SuperNova in the test tube - von Prof Dr Reinhard Renneberg, Jan Engels, Dr Hans-Georg Eisenwiener

We tell the exciting story of how mega ­fluorescence amplification was ­invented. ­
First, there was the question: How can ­previous biochemical evidence reactions ­be ­amplified million-fold to detect the bio­­chemical “needles in a haystack” (substances ­at very low concentrations) in a multicomponent system like a blood sample?

The earliest plasma marker for myocardial infarction

Fabulous FABP - von Prof Dr Reinhard Renneberg, Prof. Dr Jan F.C. Glatz

The application of Fatty Acid-Binding Protein (FABP) as a plasma marker for the diagnosis of acute myo­cardial infarction was first suggested in 1988. Currently, FABP is proven to have added value for the diagnosis­ of patients presenting with chest pain suggestive of myocardial infarction, especially in the early hours after onset of symptoms. The routine application of FABP for this purpose not only will improve patient outcome but also markedly...